Cargando…

Correction: OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation

Detalles Bibliográficos
Autores principales:	Cui, Yan, Ying, Ying, van Hasselt, Andrew, Ng, Ka Man, Yu, Jun, Zhang, Qian, Jin, Jie, Liu, Dingxie, Rhim, Johng S., Rha, Sun Young, Loyo, Myriam, Chan, Anthony T. C., Srivastava, Gopesh, Tsao, George S. W., Sellar, Grant C., Sung, Joseph J. Y., Sidransky, David, Tao, Qian
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556499/ http://dx.doi.org/10.1371/annotation/f394b95b-c731-41a3-b0dc-be25fb6a227c

Ejemplares similares

OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation
por: Cui, Yan, et al.
Publicado: (2008)

Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions
por: Birtley, James R., et al.
Publicado: (2019)

OPCML is hypermethylated in a subset of patients with metaplastic changes in their esophagus
por: Castaño-Rodríguez, Natalia, et al.
Publicado: (2018)

The Epigenetic Modifier PRDM5 Functions as a Tumor Suppressor through Modulating WNT/β-Catenin Signaling and Is Frequently Silenced in Multiple Tumors
por: Shu, Xing-sheng, et al.
Publicado: (2011)

OPCML Methylation and the Risk of Ovarian Cancer: A Meta and Bioinformatics Analysis
por: Shao, Yang, et al.
Publicado: (2021)

OPCML, a novel systems regulator of tyrosine kinase signaling in ovarian and other cancers
por: Gabra, H
Publicado: (2012)

Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas
por: Li, Lili, et al.
Publicado: (2018)

Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer
por: Xing, Xiangbin, et al.
Publicado: (2017)

Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: Erratum
por: Li, Lili, et al.
Publicado: (2022)

TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
por: Wang, Shumin, et al.
Publicado: (2010)

Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas
por: Wang, Zhaohui, et al.
Publicado: (2012)

The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
por: Hesson, Luke B, et al.
Publicado: (2009)

Epigenomic and Functional Characterization of Junctophilin 3 (JPH3) as a Novel Tumor Suppressor Being Frequently Inactivated by Promoter CpG Methylation in Digestive Cancers
por: Hu, Xiaotong, et al.
Publicado: (2017)

Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis
por: Küster, Miriam M., et al.
Publicado: (2020)

REC8 is a novel tumor suppressor gene epigenetically robustly targeted by the PI3K pathway in thyroid cancer
por: Liu, Dingxie, et al.
Publicado: (2015)

Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases
por: Wasenang, Wiphawan, et al.
Publicado: (2019)

Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer
por: Wang, Bi, et al.
Publicado: (2017)

Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation
por: Tao, Yan-Fang, et al.
Publicado: (2014)

Mitochondria Biogenesis and Bioenergetics Gene Profiles in Isogenic Prostate Cells with Different Malignant Phenotypes
por: Burch, Tanya C., et al.
Publicado: (2016)

Inactivation of the tumor suppressor p53 by long noncoding RNA RMRP
por: Chen, Yajie, et al.
Publicado: (2021)

Cytochrome b5 reductase 2 is a novel candidate tumor suppressor gene frequently inactivated by promoter hypermethylation in human nasopharyngeal carcinoma
por: Xiao, Xue, et al.
Publicado: (2013)

Hypermethylation of tumor suppressor lncRNA MEF2C-AS1 frequently happened in patients at all stages of colorectal carcinogenesis
por: Qian, Sangni, et al.
Publicado: (2022)

Key tumor suppressor genes inactivated by “greater promoter” methylation and somatic mutations in head and neck cancer
por: Guerrero-Preston, Rafael, et al.
Publicado: (2014)

Frequent Epigenetic Suppression of Tumor Suppressor Gene Glutathione Peroxidase 3 by Promoter Hypermethylation and Its Clinical Implication in Clear Cell Renal Cell Carcinoma
por: Liu, Qianling, et al.
Publicado: (2015)

Inactivation of tumor suppressor TAp63 by hepatitis B virus X protein in hepatocellular carcinoma
por: Xie, Bangxiang, et al.
Publicado: (2022)

Frequent loss of heterozygosity and altered expression of the candidate tumor suppressor gene 'FAT' in human astrocytic tumors
por: Chosdol, Kunzang, et al.
Publicado: (2009)

Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
por: Suzuki, H, et al.
Publicado: (2008)

Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
por: Suzuki, H, et al.
Publicado: (2008)

PCDH18 is frequently inactivated by promoter methylation in colorectal cancer
por: Zhou, Dan, et al.
Publicado: (2017)

Protocadherin 17 is a tumor suppressor and is frequently methylated in nasopharyngeal carcinoma
por: He, Ya, et al.
Publicado: (2019)

Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma
por: Tong, Joanna H, et al.
Publicado: (2010)

Tumor Suppressor Inactivation in the Pathogenesis of Adult T-Cell Leukemia
por: Nicot, Christophe
Publicado: (2015)

Inactivation of the Hippo tumor suppressor pathway promotes melanoma
por: Vittoria, Marc A., et al.
Publicado: (2022)

Epigenetic inactivation of the candidate tumor suppressor gene ASC/TMS1 in human renal cell carcinoma and its role as a potential therapeutic target
por: Liu, Qianling, et al.
Publicado: (2015)

Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
por: Schagdarsurengin, Undraga, et al.
Publicado: (2010)

RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma
por: Wang, Fei, et al.
Publicado: (2015)

MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation
por: Song, Yong-Xi, et al.
Publicado: (2011)

The tumor suppressor interferon regulatory factor 8 inhibits β-catenin signaling in breast cancers, but is frequently silenced by promoter methylation
por: Luo, Xinrong, et al.
Publicado: (2017)

Identification of Candidate Tumour Suppressor Genes Frequently Methylated in Renal Cell Carcinoma
por: Morris, Mark R., et al.
Publicado: (2010)

Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers
por: Feng, Weiwei, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_pujpkm6eadst9u5til7932pm9q